Contact: Kathy Wallis
University of Western Ontario
Caption: An international clinical trial led by Dr. Brian Feagan of Western University in London, Canada has found that the investigational antibody vedolizumab is an effective treatment for those suffering from ulcerative colitis and Crohn's disease when other treatments have failed.
Credit: Western University
Usage Restrictions: None
Related news release: Studies show vedolizumab is an effective treatment for Crohn's disease and ulcerative colitis